COMMUNIQUÉS West-GlobeNewswire

-
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
10/05/2025 -
Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)
10/05/2025 -
Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
10/05/2025 -
6 Best Fat Burners For Women: Top Over the Counter and Online Pills and Fat Burning Supplements For Women Weight Loss In 2025 - Wolfson Brands
10/05/2025 -
Best Fat Burners For Men 2025: Top Weight Loss Pills & Supplements For Fast Fat Loss - Wolfson Brands Ltd
10/05/2025 -
4 Best Supplements for Muscle Growth in 2025 - Legal Steroid Alternatives & Bodybuilding Supplements for Bulking and Strength - Wolfson Brands
10/05/2025 -
Activists Mark Luigi Mangione’s Birthday With Aerial Protest as Times Square Billboard on Jury Rights Explodes Online
10/05/2025 -
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
09/05/2025 -
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
09/05/2025 -
HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences
09/05/2025 -
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
09/05/2025 -
Publication relating to transparency notifications
09/05/2025 -
Publication relative à des notifications de transparence
09/05/2025 -
Olema Oncology to Participate in Upcoming Investor Conferences
09/05/2025 -
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/2025 -
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
09/05/2025 -
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
09/05/2025 -
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/2025 -
Oculis Publishes Invitation to the Annual General Meeting
09/05/2025
Pages